Corindus Vascular Robotics (CVRS) Tops Q4 EPS by 1c

Corindus Vascular Robotics (NYSE: CVRS) reported Q4 EPS of ($0.06), $0.01 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $500 thousand versus the consensus estimate of $800 thousand.

2017 Guidance

Corindus continues to expect full year 2017 revenue to be in the range of $13 million to $15 million. Corindus expects the implementation of at least 25 new cardiovascular programs in 2017.

For earnings history and earnings-related data on Corindus Vascular Robotics (CVRS) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49